Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Foie » Cirrhose du foie 18. Décembre 2014
Recherche
Gastroplattform
Cirrhose du foie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Hépatite
Cirrhose du foie
Néoplasie
Hypertonie portale
Autres
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 976  Page précédente Page suivante
   
   Articles 1 - 20 / 19503  
   
Pegylated interferon ?-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose.
Liver Int.
Xu Y, Qi W, Wang X, Zhao P, Zhang Y, Zhang Q, Qin S, Wang J.
PMID: 25513194 [PubMed - in process]


Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-naïve Patients with Chronic Hepatitis C and Advanced Liver Fibrosis/Cirrhosis.
Antimicrob Agents Chemother.
Zeuzem S, Soriano V, Asselah T, Gane EJ, Bronowicki JP, Angus P, Lohse AW, Stickel F, Müllhaupt B, Roberts S, Schuchmann M, Manns M, Bourlière M, Buti M, Stern JO, Gallivan JP, Voss F, Sabo JP, Böcher W, Mensa FJ, on behalf of the SOUND-C2 study group.
PMID: 25512403 [PubMed - as supplied by publisher]


The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis.
Acta Gastroenterol Belg.
Alempijevi? T, ?tuli? M, Popovic D, Culafic D, Dragasevic S, Milosavljevic T.
PMID: 25509200 [PubMed - in process]


Efficacy of Obeticholic Acid in Patients with Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid.
Gastroenterology.
Hirschfield GM, Mason A, Luketic V, Lindor K, Gordon S, Mayo M, Kowdley KV, Vincent C, Bodhenheimer HC Jr, Parés A, Trauner M, Marschall HU, Adorini L, Sciacca C, Beecher-Jones T, Castelloe E, Böhm O, Shapiro D.
PMID: 25500425 [PubMed - as supplied by publisher]


Identification of Minimal Hepatic Encephalopathy in Patients with Cirrhosis Based on White Matter Imaging and Bayesian Data Mining.
AJNR Am J Neuroradiol.
Chen HJ, Chen R, Yang M, Teng GJ, Herskovits EH.
PMID: 25500314 [PubMed - as supplied by publisher]


Role of portal haemodynamic parameters in prediction of oesophageal varices in cirrhotic patients.
Arab J Gastroenterol.
Mahmoud HS, Mostafa EF, Mohammed MA.
PMID: 25499211 [PubMed - as supplied by publisher]


Non-invasive diagnosis of advanced fibrosis and cirrhosis.
World J Gastroenterol.
Sharma S, Khalili K, Nguyen GC.
PMID: 25492996 [PubMed - as supplied by publisher]


Noninvasive assessment of portal hypertension in cirrhosis: Liver stiffness and beyond.
World J Gastroenterol.
Stefanescu H, Procopet B.
PMID: 25492995 [PubMed - as supplied by publisher]


Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis.
World J Gastroenterol.
Giannelli V, Di Gregorio V, Iebba V, Giusto M, Schippa S, Merli M, Thalheimer U.
PMID: 25492994 [PubMed - as supplied by publisher]


The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study.
Dig Liver Dis.
Kreisel W, Deibert P, Kupcinskas L, Sumskiene J, Appenrodt B, Roth S, Neagu M, Rössle M, Zipprich A, Caca K, Ferlitsch A, Dilger K, Mohrbacher R, Greinwald R, Sauerbruch T.
PMID: 25483910 [PubMed - as supplied by publisher]


Proton Pump Inhibitor Therapy Does Not Increase the Incidence of Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicenter Prospective Study.
J Hepatol.
Terg R, Casciato P, Garbe C, Cartier M, Stieben T, Mendizabal M, Niveyro C, Benavides J, Marino M, Colombato L, Berbara D, Silva M, Salgado P, Barreyro F, Fassio E, Gadano A, Study Group of Cirrhosis Complications of the Argentine Association for the Study of Liver Disease.
PMID: 25481567 [PubMed - as supplied by publisher]


Portal vein clamping alone confers protection against hepatic ischemia-reperfusion injury via preserving hepatocyte function in cirrhotic rats.
J Surg Res.
Hu JJ, Li CH, Wang HD, Xu WL, Zhang AQ, Dong JH.
PMID: 25481529 [PubMed - as supplied by publisher]


The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations.
Hepat Mon.
Imani F, Motavaf M, Safari S, Alavian SM.
PMID: 25477978 [PubMed]


A Multi-level Modeling Framework to Study Hepatic Perfusion Characteristics in case of Liver Cirrhosis.
J Biomech Eng.
Peeters G, Debbaut C, Cornillie P, De Schryver T, Monbaliu D, Laleman W, Segers P.
PMID: 25473885 [PubMed - as supplied by publisher]


Risks of Venous Thromboembolism in Patients with Liver Cirrhosis: A Nationwide Cohort Study in Taiwan.
J Thromb Haemost.
Ng KJ, Lee YK, Huang MY, Hsu CY, Su YC.
PMID: 25471737 [PubMed - as supplied by publisher]


Prospective Comparison of Spleen and Liver Stiffness by Using Shear-Wave and Transient Elastography for Detection of Portal Hypertension in Cirrhosis.
Radiology.
Elkrief L, Rautou PE, Ronot M, Lambert S, Dioguardi Burgio M, Francoz C, Plessier A, Durand F, Valla D, Lebrec D, Vilgrain V, Castéra L.
PMID: 25469784 [PubMed - as supplied by publisher]


Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
Lancet.
Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, McCullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E, for the NASH Clinical Research Network.
PMID: 25468160 [PubMed - as supplied by publisher]


ELF-test less accurately identifies liver cirrhosis diagnosed by liver stiffness measurement in non-Asian women with chronic hepatitis B.
J Clin Virol.
Harkisoen S, Boland GJ, van den Hoek JA, van Erpecum KJ, Hoepelman AI, Arends JE.
PMID: 25467860 [PubMed - as supplied by publisher]


Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.
Lancet.
Lawitz E, Gane E, Pearlman B, Tam E, Ghesquiere W, Guyader D, Alric L, Bronowicki JP, Lester L, Sievert W, Ghalib R, Balart L, Sund F, Lagging M, Dutko F, Shaughnessy M, Hwang P, Howe AY, Wahl J, Robertson M, Barr E, Haber B.
PMID: 25467591 [PubMed - as supplied by publisher]


The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma.
Scand J Clin Lab Invest.
Pang Q, Zhang JY, Xu XS, Song SD, Chen W, Zhou YY, Miao RC, Qu K, Liu SS, Dong YF, Liu C.
PMID: 25465804 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 19503    Page 1 de 976  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1